Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments ...

Eli Lilly stock dips after missing a priority voucher and price cut talks on rival obesity drugs. Read more here.

President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and ...

Senate Majority Leader John Thune (R-S.D.) is throwing a curveball into the shutdown fight as he plans to bring a full-year ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Eli Lilly was looking for infrastructure and an uncomplicated permit process for its $6.5M pharmaceutical manufacturing ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

Eli Lilly stock and Novo Nordisk shares fell after Trump said the list price of Ozempic, which he called “the fat-loss drug,” ...

While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...

Several sources are speculating that the potential buyer could be Eli Lilly, despite the breakdown of the pharma's ...